Skip to content
10-K

Annual Report

LEMAITRE VASCULAR INC LMAT

0001437749-25-005637

← back to feed
Filed
Feb 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 24, 2025 22.56M sh
Cash And Equivalents FY 2024 · Dec 31, 2023 $24.27M
Current Liabilities FY 2024 · Dec 31, 2023 $29.88M
Total Liabilities FY 2024 · Dec 31, 2023 $48.88M
Current Assets FY 2024 · Dec 31, 2023 $194.6M
Total Assets FY 2024 · Dec 31, 2023 $346.78M
Shares Diluted FY 2024 · Dec 31, 2022 22.17M sh
Stock Repurchased FY 2024 · Dec 31, 2022 $642K
Dividends Paid FY 2024 · Dec 31, 2022 $10.99M
Operating Cash Flow FY 2024 · Dec 31, 2022 $25.38M
Eps Diluted FY 2024 · Dec 31, 2022 $0.93
Eps Basic FY 2024 · Dec 31, 2022 $0.94
Sga Expense FY 2024 · Dec 31, 2022 $28.75M
Rd Expense FY 2024 · Dec 31, 2022 $13.29M
Net Income FY 2024 · Dec 31, 2022 $20.64M
Operating Income FY 2024 · Dec 31, 2022 $26.83M
Gross Profit FY 2024 · Dec 31, 2022 $104.9M
Cost Of Revenue FY 2024 · Dec 31, 2022 $56.76M
Revenue FY 2024 · Dec 31, 2022 $161.65M
Stockholders Equity FY 2024 · Dec 31, 2021 $254.15M